Overview

Midodrine Hydrochloride in Early Sepsis

Status:
Completed

Trial end date:
2020-05-15

Target enrollment:

Participant gender:

Summary

The investigators would like to determine if early administration of oral Midodrine in participants diagnosed with sepsis will impact blood pressures and decrease the need for and/or doses of intravenous pressor agents.

Phase:

Phase 1

Details

Lead Sponsor:

Mayo Clinic

Collaborator:

Cleveland Clinic Abu Dhabi

Treatments:

Midodrine